Diagnostic Test Segment to Hold Largest Share of Virology Market During 2021–2028
According to our latest study on “Virology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End User,” the market is projected to reach US$ 5,276.48 million by 2028 from US$ 4,108.27 million in 2021; it is expected to register a CAGR of 3.6% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the market.
Viruses such as human immunodeficiency virus (HIV), flu virus, zika virus, Ebola virus, SARS-CoV-2, and poliovirus infect large population across the world. As the virus mutate and evolve continuously, drug resistance becomes a major challenge in viral infection management among the humans and animals. A virus transmits through various media based on its type. For instance, some viruses cause respiratory viral diseases, such as flu, common cold, and respiratory syncytial virus infection, and they are transmitted via droplets generated through coughing or sneezing, whereas some gastrointestinal viral diseases are transmitted through direct contact with the feces of infected people or through contaminated food or water. As per the UNAIDS Global HIV & AIDS statistics, more than 37.7 million people across the world were infected by HIV in 2020.
Based on application, the virology market is segmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. The respiratory tract infections segment held the largest market share in 2020 and is expected to register the highest CAGR in the market during 2021–2028.
Abbott; Johnson & Johnson Services, Inc.; F. Hoffmann-LA Roche Ltd.; Thermo Fisher Scientific, Inc.; Qiagen, Illumina, Inc.; Siemens AG; GlaxoSmithKline Plc; Gilead Sciences, Inc.; and AbbVie, Inc. are among the leading companies operating in the virology market.
Report : Segments of Virology Market are as Follows:
The virology market is segmented on the basis of type, application, and end user. Based on type, the market is further segmented into diagnostic tests, viral infection controlling techniques, antiviral therapeutics, and interferons. Based on application, the market is subsegmented into skin and soft tissue infections, respiratory tract infections, GI tract infections, sexually transmitted diseases, urinary tract infection, and others. Based on end user, the virology market is segmented into hospitals, diagnostic laboratories, pharmaceutical and biotechnological companies, and research and academic institutes. On the basis of geography, the virology market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM)
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@reportsweb.com